Neoadjuvant and adjuvant chemotherapy share equivalent efficacy in improving overall survival and cancer-specific survival among muscle invasive bladder cancer patients who undergo radical cystectomy: a retrospective cohort study based on SEER database

BACKGROUND: Although neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) have been reported an 6% absolute improvement in 5-year overall survival (OS) for muscle invasive bladder cancer (MIBC), criticism still exists including the delay of surgery and the lack of accurate pathological...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Zhiping, Chen, Zhenhua, Yao, Gaoshen, Mumin, Mukhtar Adan, Wang, Yinghan, Zhu, Jiangquan, Xu, Quanhui, Chen, Wei, Liang, Hui, Wang, Zhu, Deng, Qiong, Luo, Junhang, Wei, Jinhuan, Cao, Jiazheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005995/
https://www.ncbi.nlm.nih.gov/pubmed/36915890
http://dx.doi.org/10.21037/tau-23-79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005995/
https://www.ncbi.nlm.nih.gov/pubmed/36915890
http://dx.doi.org/10.21037/tau-23-79

Ejemplares similares